Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/2/2025

Evaluation and Management of Hematuria in Adults

Initial Assessment and Confirmation

  • The American Urological Association recommends obtaining microscopic urinalysis immediately to confirm ≥3 red blood cells per high-power field, as dipstick positivity alone is insufficient and should never trigger imaging without microscopic confirmation 1, 3
  • A detailed history should be obtained, focusing on recent vigorous exercise, menstruation timing in women, recent urologic procedures, and current medications, including anticoagulants, to rule out benign causes 4, 3, 2
  • Urine culture should be performed if infection is suspected, preferably before antibiotics, though infection does not exclude concurrent malignancy 4, 3, 2
  • Repeat urinalysis after treating benign causes to confirm persistence—if hematuria resolves, no further workup is needed 1, 2

Risk Stratification for Malignancy

  • Gross hematuria carries a 30-40% malignancy risk and mandates urgent urologic referral with cystoscopy and CT urography, even if self-limited 5, 6, 2
  • Age >35-40 years, smoking history >30 pack-years, and occupational exposure to certain chemicals represent high-risk factors for urothelial carcinoma 1, 2, 7
  • Irritative voiding symptoms without documented infection also warrant further evaluation 4, 2

Complete Urologic Evaluation

  • Multiphasic CT urography is the preferred imaging modality, with unenhanced, nephrographic, and excretory phases to detect renal cell carcinoma, transitional cell carcinoma, and urolithiasis 1, 2, 7
  • Cystoscopy is mandatory for all adults ≥35 years with confirmed microscopic hematuria and for all patients with gross hematuria regardless of age 4, 1, 2
  • Flexible cystoscopy is preferred over rigid due to less pain, fewer post-procedure symptoms, and equivalent or superior diagnostic accuracy 6, 2, 7

Concurrent Nephrologic Assessment

  • Examine urinary sediment for dysmorphic RBCs and red blood cell casts to assess for glomerular disease 1, 2, 7
  • Check for proteinuria using spot urine protein-to-creatinine ratio, as significant proteinuria with hematuria indicates likely glomerular disease 2, 7
  • Assess blood pressure, as hypertension with hematuria and proteinuria suggests glomerulonephritis 4, 2

Critical Pitfalls to Avoid

  • Never attribute hematuria solely to anticoagulation or antiplatelet therapy, as these medications may unmask underlying pathology but do not cause hematuria themselves 4, 3, 2
  • Do not prescribe antibiotics for persistent hematuria without documented infection, as this delays cancer diagnosis and provides false reassurance 2
  • Never ignore gross hematuria, even if self-limited, due to the 30-40% malignancy risk 5, 6, 2

Follow-Up Protocol if Initial Workup Negative

  • Repeat urinalysis at 6, 12, 24, and 36 months with blood pressure monitoring at each visit 4, 1, 7
  • Immediate re-evaluation is warranted if there is recurrent gross hematuria, significant increase in microscopic hematuria, new urologic symptoms, or development of hypertension/proteinuria 4, 2, 7